Jamie DePolo
Jamie DePolo specializes in translating complex breast cancer research into actionable information for patients, with particular expertise in treatment innovations and their real-world implications for diverse patient populations. Her work consistently bridges the gap between clinical trial data and patient decision-making through precise explanation of study methodologies and limitations.
Research Translation Methodology
DePolo systematically breaks down clinical studies by detailing patient populations, treatment protocols, and statistical significance without oversimplification. She consistently identifies which patient subgroups benefit most from specific treatments, such as noting that "women diagnosed with hormone receptor-positive breast cancer, including women with a BRCA mutation, can safely become pregnant after breast cancer". Her analysis of metastatic recurrence risk includes precise decade-by-decade comparisons showing "women diagnosed since 2000 have about a 20% lower risk of metastatic recurrence than women diagnosed in the 1990s".
Treatment Innovation Coverage
She maintains comprehensive tracking of emerging therapies, providing clear differentiation between drugs with similar mechanisms. Her reporting on oligometastatic breast cancer demonstrates nuanced understanding of evolving definitions, acknowledging "there really is no universal definition" while explaining clinical implications of varying lesion counts. DePolo details specific FDA approvals like Truqap and Orserdu with exact indications, noting expanded use for "metastatic, hormone receptor-positive breast cancer, rather than only triple-negative disease".
She connects treatment advances to quality-of-life outcomes, such as explaining how "less treatment means a lower risk of side effects, including lymphedema" when lymph node treatment can be avoided.
Patient-Centered Research Analysis
DePolo consistently frames research through patient impact, highlighting studies showing "a few minutes of vigorous exercise each day is enough to reduce breast cancer risk" alongside more intensive interventions. Her podcast interviews with clinicians like Dr. Jennifer Plichta explore practical implementation challenges, such as the absence of specific diagnosis codes for oligometastatic disease that complicate treatment documentation. She emphasizes demographic considerations in screening guidelines, noting recommendations that "all women, especially Black and Ashkenazi Jewish women, should have a breast cancer risk assessment by age 25".
Her coverage of PTSD after cancer diagnosis addresses both prevalence ("up to 25% of women diagnosed with breast cancer were at risk") and delayed onset patterns.
Conference Reporting Rigor
As a regular attendee of major symposia including the San Antonio Breast Cancer Symposium, DePolo provides timely distillation of key findings without hype. Her SABCS 2025 coverage prioritized practice-changing research while contextualizing preliminary findings, maintaining Breastcancer.org's evidence-based standard. She interviews researchers directly at conferences, as demonstrated by her GRASP-sponsored reception discussions with advocates and clinicians at SABCS 2022.
This approach ensures her reporting reflects actual presentation content rather than press release interpretations.
4 more health journalists.
Aislinn Antrim
Aislinn Antrim is an associate editorial director at Pharmacy Times and a journalist who connects clinical advances, regulation, and the changing role of pharmacists. She writes pharmacy-centered health coverage on chronic disease therapeutics, specialty and oncology care, workforce pressures, and advocacy. Her reporting explains FDA actions, policy shifts, drug pipelines, and the real-world effects of new evidence on patient care and pharmacy practice. She often uses interviews and expert conversations to show how pharmacists improve adherence, manage side effects, navigate access and benefits, and coordinate care with prescribers. She also covers burnout, staffing strain, and the future of pharmacy practice, with an eye on how policy and economics shape work at the dispenser.
Alex Cabrero
Alex Cabrero is an Emmy award-winning KSL TV reporter who covers where health, safety and community life meet, always focused on how decisions and events affect everyday people. He has been with KSL since 2004, bringing long experience in breaking news, public service coverage and human-centered features. His beat includes public health, emergency response, technology, local infrastructure, environment and science, framed through community well-being and resilience. He reports on issues like mental health initiatives, law enforcement staffing, environmental hazards, rescues, wildfire detection tools, land-use fights and scientific discoveries, making technical and policy details clear for a general audience. He also produces many positive, everyday-life features on families, veterans, farmers, sports and local traditions. His style is direct and conversational, often built around a central person or family whose experience carries the story across TV, digital and social platforms.
Alexandra Frost
Alexandra Frost is a freelance journalist and content marketing writer who turns expert-backed health and family guidance into clear, practical service stories. She covers consumer health, wellness, nutrition, preventive care, medical research, parenting, kids’ mental health, education, products, and lifestyle. Her reporting explains concerns such as inflammation, urinary symptoms, fiber, lung cancer screening, pain treatment, mobility, family dynamics, children’s technology use, and school readiness. She profiles clinicians and scientists, connects research to everyday decisions, and focuses on what readers should watch for, ask, or change. Frost currently writes across multiple outlets, including Good Housekeeping, Cincinnati Magazine, Wirecutter, Popular Science, Success, Healthline, Parents, Women’s Health, Reader’s Digest, Today’s Parent, the Atlantic, the Washington Post, TIME, Consumer Reports, Business Insider, and National Geographic. She also works as a freelance editor, media consultant, and content strategist.
Alexandra Pattillo
Alexandra Pattillo is a freelance journalist who pairs rigorous health and science reporting with intimate accounts of patients’ lives. She covers health, science and wellness for the BBC and other major outlets, including National Geographic, The New York Times, The Atlantic, The Guardian, Outside, CNN and Inverse. Her beat includes eating disorders, women’s health, perinatal mental health, brain health, youth sports, concussion, long-term Covid symptoms, attention, habits and behavioral science. She reports on emerging treatments such as psychedelic-assisted therapy for anorexia, testing evidence, safety and relapse risk. She explains complex research in plain language and examines how it shapes everyday choices. Her reporting uses in-depth interviews with patients, families, clinicians, researchers and coaches. Through the BBC’s Health Gap column, she also covers stigma, unequal access to care and gaps between lived experience and standard medical pathways.